Personal information

Emails & domains

Verified email domains

Other IDs

Scopus Author ID: 57194345379
SciProfiles: 2087083
ResearcherID: AFM-8311-2022

Countries

Spain

Activities

Collapse all

Employment (2)

IIS La Fe: Valencia, ES

2019-10-01 to present | Investigator (Pharmacy)
Employment
Source: Self-asserted source
Antonio Solana-Altabella

Hospital Universitari i Politècnic La Fe: Valencia, ES

2023-01-15 to 2026-01-14 (Pharmacy)
Employment
Source: Self-asserted source
Antonio Solana-Altabella

Education and qualifications (1)

CEU Cardinal Herrera University: Valencia, Valencia, ES

2009 to 2014 | Graduado en Farmacia (Farmacia)
Qualification
Source: Self-asserted source
Antonio Solana-Altabella

Professional activities (2)

Sociedad Valenciana de Farmacia Hospitalaria: Valencia, Valencia, ES

2015-11-01 to present
Membership
Source: Self-asserted source
Antonio Solana-Altabella

Sociedad Española de Farmacia Hospitalaria: Madrid, ES

2015-11-01 to present
Membership
Source: Self-asserted source
Antonio Solana-Altabella

Works (33)

Treatment patterns and outcomes in secondary acute myeloid leukemia arising after hypomethylating agents: PETHEMA registry study

Cancer
2025 | Journal article
DOI: 10.1002/CNCR.35696
WOSUID: WOS:001389310900001
Contributors: Lloret-Madrid, Pilar; Boluda, Blanca; Martinez-Lopez, Joaquin; Bergua, Juan; Rodriguez Arboli, Eduardo; Labrador, Jorge; Sossa, Claudia; Gil, Cristina; Algarra, Lorenzo; Lavilla-Rubira, Esperanza et al.
Source: check_circle
Web of Science Researcher Profile Sync

Pharmacogenetics in Response to Biological Agents in Inflammatory Bowel Disease: A Systematic Review

International Journal of Molecular Sciences
2025-02-19 | Journal article
DOI: 10.3390/ijms26041760
Contributors: Octavio Ballesta-López; Mayte Gil-Candel; María Centelles-Oria; Juan Eduardo Megías-Vericat; Antonio Solana-Altabella; Hugo Ribes-Artero; Pilar Nos-Mateu; Javier García-Pellicer; José Luis Poveda-Andrés
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Clinical Features and Outcomes in 228 Patients Diagnosed with Blastic Plasmocytoid Dendritic Cell Neoplasm: A Pethema/PALG Study

Blood
2024 | Journal article
DOI: 10.1182/BLOOD-2024-205172
Contributors: Irene Navarro Vicente; Antonio Solana-Altabella; Marta Sobas; Josefina Serrano; Magdalena Karasek; Manuel Perez Encinas; Jorge Labrador; Cristina de la Fuente; Olga Salamero; Rafael Colmenares Gil et al.
Source: check_circle
Web of Science Researcher Profile Sync

Outcomes after intensive chemotherapy for secondary and myeloid-related changes acute myeloid leukemia patients aged 60 to 75 years old: a retrospective analysis from the PETHEMA registry

Haematologica
2024 | Journal article
DOI: 10.3324/HAEMATOL.2022.282506
WOSUID: WOS:001138226400034
Contributors: Martinez-Cuadron, David; Megias-Vericat, Juan E.; Gil, Cristina; Bernal, Teresa; Tormo, Mar; Martinez-Sanchez, Pilar; Rodriguez-Medina, Carlos; Serrano, Josefina; Herrera, Pilar; Simon, Jose A. Perez et al.
Source: check_circle
Web of Science Researcher Profile Sync

Treatment Approaches for Blastic Plasmacytoid Dendritic Cell Neoplasm: Data from the Pethema and PALG Epidemiologic Registry

Blood
2024 | Journal article
DOI: 10.1182/BLOOD-2024-205106
Contributors: Antonio Solana-Altabella; Irene Navarro Vicente; Marta Sobas; Josefina Serrano; Magdalena Karasek; Manuel Perez Encinas; Jorge Labrador; Cristina de la Fuente; Olga Salamero; Rafael Colmenares et al.
Source: check_circle
Web of Science Researcher Profile Sync

A systematic review of venetoclax for the treatment of unfit AML patients in real-world: is all that glitters gold?

Annals of Hematology
2024-08-16 | Journal article
DOI: 10.1007/s00277-024-05891-w
Contributors: Antonio Solana-Altabella; Rebeca Rodríguez-Veiga; David Martínez-Cuadrón; Pau Montesinos
Source: check_circle
Crossref

Clinical Features and Treatment in Patients Diagnosed with Blastic Plasmacytoid Dendritic Cell Neoplasm: Interim Analysis from the Pethema Epidemiologic Registry (EPI-BLAS study)

Blood
2023 | Journal article
DOI: 10.1182/BLOOD-2023-190296
WOSUID: WOS:001159740306280
Contributors: Vicente, Navarro; Lloret Madrid, Pilar; Solana-Altabella, Antonio; Martinez Sanchez, Pilar; Angeles Foncillas, Maria; Cervero, Carlos; Noriega, Victor; Garrastazul Sanchez, Maria Paz; Alonso Alonso, Jose Maria; De Rueda Ciller, Beatriz et al.
Source: check_circle
Web of Science Researcher Profile Sync

Developing a telepharmacy programme with home medication dispensing and informed delivery in a tertiary hospital: description of the model and analysis of the results

European Journal of Hospital Pharmacy
2023-03 | Journal article
DOI: 10.1136/ejhpharm-2021-003194
Contributors: Mayte Gil-Candel; Antonio Solana-Altabella; Esther Vicente-Escrig; Aarón Puplá-Bartoll; Julia Bodega Azuara; Pablo Pérez-Huertas; Raul Ferrando Piqueres
Source: check_circle
Crossref

Drug-drug interactions associated with FLT3 inhibitors for acute myeloblastic leukemia: current landscape

Expert Review of Clinical Pharmacology
2023-02-01 | Journal article
DOI: 10.1080/17512433.2023.2174523
Contributors: Antonio Solana-Altabella; Juan Eduardo Megías-Vericat; Octavio Ballesta-López; David Martínez-Cuadrón; Pau Montesinos
Source: check_circle
Crossref

Influence of pharmacokinetic/pharmacodynamic ratio on vancomycin treatment response in pediatric patients with <i>Staphylococcus aureus</i> bacteremia

Minerva Pediatrics
2022 | Journal article
DOI: 10.23736/S2724-5276.18.04978-2
WOSUID: WOS:000921552200004
Contributors: Ruiz, Jesus; Garcia-Robles, Ana; Marques, Maria R.; Company, Maria J.; Solana, Antonio; Poveda, Jose L.
Source: check_circle
Web of Science Researcher Profile Sync

Incidence and risk factors for development of cardiac toxicity in adult patients with newly diagnosed acute myeloid leukemia

Research Square
2022-12-27 | Journal article
DOI: 10.21203/rs.3.rs-2397518/v1
Contributors: Blanca Boluda; Antonio Solana-Altabella; Isabel Cano; David Martinez-Cuadron; Evelyn Acuña-Cruz; Laura Torres-Miñana; Rebeca Rodriguez-Veiga; Irene Navarro-Vicente; David Martínez-Campuzano; Raquel García-Ruiz et al.
Source: check_circle
Dimensions
grade
Preferred source (of 4)‎

Observational study to evaluate discontinuation of monotherapy with cobicistat-boosted darunavir in patients with human immunodeficiency virus

Medicine
2022-12-09 | Journal article
DOI: 10.1097/md.0000000000032208
Contributors: Antonio Solana-Altabella; Emilio Monte-Boquet; Marta Montero; Pablo Pérez-Huertas; Maria Jesús Cuéllar-Monreal; Miguel Salavert; José Luis Poveda-Andrés
Source: check_circle
Dimensions
grade
Preferred source (of 2)‎

P511: RISK FACTORS AND INCIDENCE OF CARDIAC EVENTS IN A LARGE COHORT OF 525 ADULT PATIENTS WITH NEWLY DIAGNOSED NON-M3 ACUTE MYELOID LEUKEMIA

HemaSphere
2022-06 | Journal article
DOI: 10.1097/01.hs9.0000844932.13015.69
Contributors: B. Boluda; A. Solana-Altabella; I. Cano; D. Martínez-Cuadrón; E. Acuña-Cruz; L. Torres-Miñana; R. Rodríguez-Veiga; D. Martínez-Campuzano; R. García-Ruiz; P. Lloret et al.
Source: check_circle
Dimensions

Healthcare Resource Utilization among Patients between 60&ndash;75 Years with Secondary Acute Myeloid Leukemia Receiving Intensive Chemotherapy Induction: A Spanish Retrospective Observational Study

Cancers
2022-04 | Journal article | Author
DOI: 10.3390/cancers14081921
Contributors: Antonio Solana-Altabella; Juan Eduardo Megías-Vericat; Octavio Ballesta-López; Blanca Boluda; Isabel Cano; Evelyn Acuña-Cruz; Rebeca Rodríguez-Veiga; Laura Torres-Miñana; Claudia Sargas; Miguel Sanz et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute
grade
Preferred source (of 2)‎

Systematic Review of Pharmacogenetics of ABC and SLC Transporter Genes in Acute Myeloid Leukemia

Pharmaceutics
2022-04 | Journal article | Author
DOI: 10.3390/pharmaceutics14040878
Contributors: Juan Eduardo Megías-Vericat; David Martínez-Cuadrón; Antonio Solana-Altabella; JOSE LUIS POVEDA; Pau Montesinos
Source: check_circle
Multidisciplinary Digital Publishing Institute
grade
Preferred source (of 2)‎

4CPS-176 Oral ivermectin effectiveness in the treatment of permethrin-resistant scabies: a descriptive and retrospective observational study

2022-03-23 | Book chapter
DOI: 10.1136/ejhpharm-2022-eahp.185
Contributors: M Fernandez-Sanchez; E Monte-Boquet; MJ Cuellar-Monreal; MV Tarazona-Casany; A Garcia-Robles; E Guerrer-Hurtado; I Beltran-Garcia; P Polo-Montanero; A Cruz-Sanchez; A Solana-Altabella et al.
Source: check_circle
Dimensions

Emerging FLT3 inhibitors for the treatment of acute myeloid leukemia

Expert Opinion on Emerging Drugs
2022-01-02 | Journal article
DOI: 10.1080/14728214.2021.2009800
Contributors: Antonio Solana-Altabella; Octavio Ballesta-López; Juan Eduardo Megías-Vericat; David Martínez-Cuadrón; Pau Montesinos
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Evolving patterns of care and outcomes in relapsed/refractory FLT3 mutated acute myeloid leukemia adult patients

Leukemia and Lymphoma
2021 | Journal article
DOI: 10.1080/10428194.2021.1938031
EID:

2-s2.0-85107774851

Part of ISSN: 10292403 10428194
Contributors: Boluda, B.; Martínez-Cuadrón, D.; Algarra, L.; Cano, I.; Sayas, M.J.; Acuña-Cruz, E.; Blanco, A.; Marco-Ayala, J.; DeLapuerta, R.; Díaz-González, Á. et al.
Source: Self-asserted source
Antonio Solana-Altabella via Scopus - Elsevier
grade
Preferred source (of 2)‎

Impact of combinations of single-nucleotide polymorphisms of anthracycline transporter genes upon the efficacy and toxicity of induction chemotherapy in acute myeloid leukemia

Leukemia and Lymphoma
2021 | Journal article
DOI: 10.1080/10428194.2020.1839650
EID:

2-s2.0-85095745638

Part of ISSN: 10292403 10428194
Contributors: Megías-Vericat, J.E.; Martínez-Cuadrón, D.; Herrero, M.J.; Rodríguez-Veiga, R.; Solana-Altabella, A.; Boluda, B.; Ballesta-López, O.; Cano, I.; Acuña-Cruz, E.; Cervera, J. et al.
Source: Self-asserted source
Antonio Solana-Altabella via Scopus - Elsevier
grade
Preferred source (of 4)‎

Healthcare resource utilization in adult patients with relapsed/refractory FLT3 mutated acute myeloid leukemia: A retrospective chart review from Spain

European Journal of Haematology
2021-05 | Journal article
DOI: 10.1111/ejh.13604
Part of ISSN: 0902-4441
Part of ISSN: 1600-0609
Source: Self-asserted source
Antonio Solana-Altabella
grade
Preferred source (of 3)‎

Extracorporeal photopheresis vs standard therapies for steroid‐refractory chronic graft‐vs‐host disease: Pharmacoeconomic assessment of hospital resource use in Spain

Journal of Clinical Apheresis
2021-05-08 | Journal article
DOI: 10.1002/jca.21901
Part of ISSN: 0733-2459
Part of ISSN: 1098-1101
Source: Self-asserted source
Antonio Solana-Altabella
grade
Preferred source (of 4)‎

4CPS-257 Relevance of ritonavir interactions in HIV treatments that involve treatment modification

European Journal of Hospital Pharmacy
2021-03-14 | Book chapter
DOI: 10.1136/ejhpharm-2021-eahpconf.89
Contributors: I Beltrán García; MJ Cuellar-Monreal; M Centelles-Oria; T Palanques-Pastor; E Monte-Boquet; A García-Robles; MV Tarazona-Casany; JL Poveda-Andrés; R Iglesias-Gomez; O Ballesta-López et al.
Source: check_circle
Dimensions

Influence of polymorphisms in anthracyclines metabolism genes in the standard induction chemotherapy of acute myeloid leukemia

Pharmacogenetics and Genomics
2021-03-05 | Journal article
DOI: 10.1097/fpc.0000000000000431
Part of ISSN: 1744-6872
Source: Self-asserted source
Antonio Solana-Altabella
grade
Preferred source (of 3)‎

Gilteritinib use in the treatment of relapsed or refractory acute myeloid leukemia with a FLT3 mutation

Future Oncology
2021-01 | Journal article
DOI: 10.2217/fon-2020-0700
Part of ISSN: 1479-6694
Part of ISSN: 1744-8301
Source: Self-asserted source
Antonio Solana-Altabella
grade
Preferred source (of 4)‎

Precision medicine in acute myeloid leukemia: where are we now and what does the future hold?

Expert Review of Hematology
2020-10-02 | Journal article
DOI: 10.1080/17474086.2020.1818559
Part of ISSN: 1747-4086
Part of ISSN: 1747-4094
Source: Self-asserted source
Antonio Solana-Altabella
grade
Preferred source (of 4)‎

Drug-drug interactions of newly approved small molecule inhibitors for acute myeloid leukemia

Annals of Hematology
2020-09 | Journal article
DOI: 10.1007/s00277-020-04186-0
Part of ISSN: 0939-5555
Part of ISSN: 1432-0584
Source: Self-asserted source
Antonio Solana-Altabella
grade
Preferred source (of 3)‎

Intravitreal melphalan therapy for vitreous seeds in retinoblastoma: Implementation and outcomes of a new chemotherapy protocol

Journal of Oncology Pharmacy Practice
2020-02-17 | Journal article
DOI: 10.1177/1078155220904410
Part of ISSN: 1078-1552
Part of ISSN: 1477-092X
Source: Self-asserted source
Antonio Solana-Altabella
grade
Preferred source (of 4)‎

Computer vision-based analytical chemistry applied to determining iron in commercial pharmaceutical formulations.

Talanta
2018-06 | Journal article
DOI: 10.1016/j.talanta.2018.06.008
PMID: 30029386
Contributors: Solana-Altabella A; Sánchez-Iranzo MH; Bueso-Bordils JI; Lahuerta-Zamora L; Mellado-Romero AM
Source: Self-asserted source
Antonio Solana-Altabella via Europe PubMed Central
grade
Preferred source (of 4)‎

Influence of pharmacokinetic/pharmacodynamic ratio on vancomycin treatment response in paediatric patients with Staphylococcus aureus bacteremia.

Minerva pediatrica
2018-04 | Journal article
DOI: 10.23736/s0026-4946.18.04978-2
PMID: 29651827
Contributors: Ruiz J; García-Robles A; Marqués MR; Company MJ; Solana A; Poveda JL
Source: Self-asserted source
Antonio Solana-Altabella via Europe PubMed Central
grade
Preferred source (of 2)‎

Pre and post intervention study of antiblastic drugs contamination surface levels at a Pharmacy Department Compounding Area using a closed system drug transfer device and a decontamination process.

Regulatory toxicology and pharmacology : RTP
2018-03 | Journal article
DOI: 10.1016/j.yrtph.2018.03.001
PMID: 29510165
Contributors: Valero S; López-Briz E; Vila N; Solana A; Melero M; Poveda JL
Source: Self-asserted source
Antonio Solana-Altabella via Europe PubMed Central
grade
Preferred source (of 3)‎

Haemodialysis significantly reduces serum levetiracetam levels inducing epileptic seizures: Case report.

Journal of clinical pharmacy and therapeutics
2017-05 | Journal article
DOI: 10.1111/jcpt.12568
PMID: 28555936
Contributors: Company-Albir MJ; Ruíz-Ramos J; Solana Altabella A; Marqués-Miñana MR; Vicent C; Poveda JL
Source: Self-asserted source
Antonio Solana-Altabella via Europe PubMed Central
grade
Preferred source (of 2)‎

CP-078 Prostaglandin E1 injection after arterial compromise related to hyaluronic acid filler

European Journal of Hospital Pharmacy
2017-02-25 | Book chapter
DOI: 10.1136/ejhpharm-2017-000640.77
Contributors: H Ribes; JE Megías; JM Ricart; A Solana; JL Poveda
Source: check_circle
Dimensions

CP-139 Evaluation of activity of total parenteral nutrition in a hospital pharmacy

European Journal of Hospital Pharmacy
2017-02-25 | Book chapter
DOI: 10.1136/ejhpharm-2017-000640.138
Contributors: M Martin Cerezuela; A Vazquez Polo; E López Briz; R Luna Reina; C Favieres Puigcerver; MJ Company Albir; H Ribes Artero; A Solana Altabella; A Ferrada Gasco; JL Poveda Andrés
Source: check_circle
Dimensions

Peer review (4 reviews for 1 publication/grant)

Review activity for Cancers. (4)
How many people are using ORCID?